Hormonal replacement therapy and gynecological cancer.
The problem of quality of life and lifestyle in elderly women is today a very important social problem all over the world but particularly in rich western countries. Life expectancy of the population will be longer and longer in the future and for both females and males the biological involution correlated with the aging process must be delayed. The gonadal hormones stimulate the healthy state of the entire body (heart, skin, brain, bones, urogenital apparatus and so on) and consequently hormonal replacement therapy (HRT) is mandatory. In women the biological clock of menopause allows us to intervene at the right time, with personalized estrogenic, estroprogestinic or estroandrogenic treatments. Health benefits and groundless risks allow today a careful hormonal management even in women treated for gynaecological cancers (breast and endometrium as well).
Gynecologic Institute of Padua University, Italy.
A
A
Onnis
M
M
Marchetti
D000368:Aged; D000369:Aged, 80 and over; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000139:chemically induced*; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008017:Life Expectancy; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects / Q000502:physiology*; D011374:Progesterone / Q000627:therapeutic use
D004967:Estrogens; D011374:Progesterone